Regardless of the sequential decrease in Current Liabilities, during the second quarter 2026, Quick Ratio deteriorated to 0.05 below P3 Health Partners Inc 's average Quick Ratio.

Within Medical Equipment & Supplies industry 188 other companies have achieved higher Quick Ratio than P3 Health Partners Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 3630 to 4012.

Explain Quick Ratio?
How much Cash & cash equivalents PIII�s has?
What are PIII�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PIII Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	-23.05 %	3.64 %	-0.66 %	4.6 %	43.36 %
Y / Y Cash & cash equivalent Change	-44.86 %	-36.39 %	-35.56 %	-40.1 %	-47.21 %
Quick Ratio MRQ	0.05	0.05	0.05	0.09	0.08
PIII's Total Ranking	# 4012	# 3630	# 3819	# 3088	# 2928
Seq. Current Liabilities Change	-26.05 %	4.42 %	18.7 %	-16.05 %	-0.4 %
Seq. Cash & cash equivalent Change	-16.57 %	1.94 %	-33.68 %	-2.25 %	-3.74 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 189
Healthcare Sector	# 869
Overall Market	# 4012

Quick Ratio Statistics
High	Average	Low
127.23	10.36	0
(Mar 31 2021)		(Dec 31 2021)

Financial Statements
P3 Health Partners Inc 's Current Liabilities	$ 389 Millions	Visit PIII's Balance sheet
P3 Health Partners Inc 's Cash & cash equivalent	$ 21 Millions	Visit PIII's Balance sheet
Source of PIII's Sales		Visit PIII's Sales by Geography

Cumulative P3 Health Partners Inc 's Quick Ratio

PIII's Quick Ratio for the trailling 12 Months

PIII Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	-4.3 %	10.53 %	21.37 %	39.69 %	53.6 %
Y / Y Cash & cash equivalent TTM Growth	-39.32 %	-41.01 %	-30.06 %	-22.27 %	-4.66 %
Quick Ratio TTM	0.06	0.06	0.07	0.08	0.09
Total Ranking TTM	# 4116	# 3202	# 3014	# 3229	# 2780
Seq. Current Liabilities TTM Growth	-5.95 %	0.95 %	-0.17 %	0.97 %	8.62 %
Seq. Cash & cash equivalent TTM Growth	-13.65 %	-10.32 %	-8.89 %	-13.99 %	-16.05 %

Quick ratio ranking by company, industry and sector >> Back to PIII Financial Strength Comparisons >> Go to Compare PIII Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in PIII's Current Liabilities to $388.58 millions, cumulative Quick Ratio to 0.06 below the PIII average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 207 other companies have achieved higher Quick Ratio than P3 Health Partners Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3202 to 4116.

Explain Quick Ratio?
How much Cash & cash equivalents PIII�s has?
What are PIII�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 208
Healthcare Sector	# 912
Within the Market	# 4116

trailing twelve months Quick Ratio Statistics
High	Average	Low
0.89	0.2	0.06
(Jun 30 2022)		(Jun 30 2026)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Zimmer Biomet Holdings Inc	0.14	$ 410.000 Millions	$ 3,013.500 Millions
Nexgel Inc	0.12	$ 1.692 Millions	$ 14.440 Millions
Ufp Technologies Inc	0.12	$ 9.045 Millions	$ 78.304 Millions
Solventum Corporation	0.11	$ 403.000 Millions	$ 3,663.000 Millions
Nakamoto Inc	0.11	$ 19.072 Millions	$ 179.474 Millions
Petvivo Holdings Inc	0.10	$ 0.135 Millions	$ 1.313 Millions
The Pennant Group Inc	0.10	$ 15.273 Millions	$ 152.406 Millions
Non Invasive Monitoring Systems Inc	0.10	$ 0.160 Millions	$ 1.607 Millions
Boston Scientific Corporation	0.10	$ 749.000 Millions	$ 7,530.000 Millions
Integer Holdings Corporation	0.10	$ 21.375 Millions	$ 217.141 Millions
Bellevue Life Sciences Acquisition Corp	0.10	$ 1.500 Millions	$ 15.734 Millions
National Vision Holdings Inc	0.09	$ 35.998 Millions	$ 383.026 Millions
Becton Dickinson And Company	0.09	$ 864.000 Millions	$ 9,404.000 Millions
Vivos Therapeutics Inc	0.09	$ 1.774 Millions	$ 20.389 Millions
The Cooper Companies Inc	0.08	$ 154.900 Millions	$ 1,866.600 Millions
Infusystem Holdings Inc	0.06	$ 0.964 Millions	$ 15.300 Millions
Vsee Health Inc	0.06	$ 0.454 Millions	$ 8.139 Millions
P3 Health Partners Inc	0.05	$ 21.272 Millions	$ 388.581 Millions
Henry Schein Inc	0.05	$ 157.000 Millions	$ 3,488.000 Millions
Yunhong Green Cti Ltd	0.04	$ 0.320 Millions	$ 8.371 Millions
3m Company	0.03	$ 387.000 Millions	$ 11,379.000 Millions
Vycor Medical Inc	0.03	$ 0.165 Millions	$ 4.930 Millions
Dror Ortho-Design, Inc.	0.02	$ 0.085 Millions	$ 4.100 Millions
Nu med Plus Inc	0.02	$ 0.005 Millions	$ 0.280 Millions
Enovis Corp	0.02	$ 12.563 Millions	$ 735.625 Millions
Agape Atp Corporation	0.02	$ 0.045 Millions	$ 2.939 Millions

Date modified: 2026-08-12T20:41:26+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.